131 related articles for article (PubMed ID: 38153394)
1. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Fatty Liver-Related Indices in a Japanese Population.
Moriyama K
Metab Syndr Relat Disord; 2024 Apr; 22(3):190-198. PubMed ID: 38153394
[No Abstract] [Full Text] [Related]
2. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.
Moriyama K; Inoue N; Imai J; Masuda Y; Yamada C; Kishimoto N; Takashimizu S; Kubo A; Nishizaki Y
Metab Syndr Relat Disord; 2023 Nov; 21(9):489-496. PubMed ID: 37878804
[No Abstract] [Full Text] [Related]
3. Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang.
Guo Y; Hu Y; Yang J; Ma R; Zhang X; Guo H; Wang X; Li Y; Peng X; Zhang S; He J; Guo S
Eur J Med Res; 2023 Dec; 28(1):555. PubMed ID: 38042816
[TBL] [Abstract][Full Text] [Related]
4. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.
Otsubo N; Fukuda T; Cho G; Ishibashi F; Yamada T; Monzen K
Intern Med; 2023 Aug; 62(16):2307-2319. PubMed ID: 36517035
[TBL] [Abstract][Full Text] [Related]
5. Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome.
Liu CC; Huang SP; Lee YC; Lee CH; Huang TY; Geng JH; Chang CW; Lin CY; Juan YS; Wu WJ; Hsieh TJ
Front Endocrinol (Lausanne); 2023; 14():1252774. PubMed ID: 37854195
[TBL] [Abstract][Full Text] [Related]
6. Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease.
Han AL
Diabetol Metab Syndr; 2022 Mar; 14(1):44. PubMed ID: 35317824
[TBL] [Abstract][Full Text] [Related]
7. Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD.
Chen J; Mao X; Deng M; Luo G
Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):394-401. PubMed ID: 36695773
[TBL] [Abstract][Full Text] [Related]
8. Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.
Barrea L; Muscogiuri G; Modica R; Altieri B; Pugliese G; Minotta R; Faggiano A; Colao A; Savastano S
Front Endocrinol (Lausanne); 2021; 12():649496. PubMed ID: 33815296
[TBL] [Abstract][Full Text] [Related]
9. Modified triglyceride-glucose index indices are reliable markers for predicting risk of metabolic dysfunction-associated fatty liver disease: a cross-sectional study.
Kim AH; Son DH; Lee YJ
Front Endocrinol (Lausanne); 2023; 14():1308265. PubMed ID: 38317718
[TBL] [Abstract][Full Text] [Related]
10. Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex.
Matsubayashi Y; Fujihara K; Yamada-Harada M; Mitsuma Y; Sato T; Yaguchi Y; Osawa T; Yamamoto M; Kitazawa M; Yamada T; Kodama S; Sone H
Cardiovasc Diabetol; 2022 Jun; 21(1):90. PubMed ID: 35655263
[TBL] [Abstract][Full Text] [Related]
11. Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-associated fatty liver disease: usefulness of non-invasive steatosis predictive scores.
Capela TL; Silva VM; Freitas M; Arieira C; Gonçalves TC; de Castro FD; Magalhães J; Cotter J
BMC Gastroenterol; 2023 Dec; 23(1):437. PubMed ID: 38093213
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease.
Han AL; Lee HK
Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888788
[TBL] [Abstract][Full Text] [Related]
13. Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults.
Duan S; Yang D; Xia H; Ren Z; Chen J; Yao S
Front Endocrinol (Lausanne); 2022; 13():1004855. PubMed ID: 36187093
[TBL] [Abstract][Full Text] [Related]
14. [Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].
Xia B; He H; Qin K; Li SQ; An ZM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):591-595. PubMed ID: 37248589
[TBL] [Abstract][Full Text] [Related]
15. Validation of five hepatic steatosis algorithms in metabolic-associated fatty liver disease: A population based study.
Liu Y; Liu S; Huang J; Zhu Y; Lin S
J Gastroenterol Hepatol; 2022 May; 37(5):938-945. PubMed ID: 35174539
[TBL] [Abstract][Full Text] [Related]
16. The contribution of vitamin D insufficiency to the onset of steatotic liver disease among individuals with metabolic dysfunction.
Lee SB; Jin MH; Yoon JH
Sci Rep; 2024 Mar; 14(1):6714. PubMed ID: 38509247
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic ability using fatty liver and metabolic markers for metabolic-associated fatty liver disease stratified by metabolic/glycemic abnormalities.
Okada A; Yamada G; Kimura T; Hagiwara Y; Yamaguchi S; Kurakawa KI; Nangaku M; Yamauchi T; Matsuyama Y; Kadowaki T
J Diabetes Investig; 2023 Mar; 14(3):463-478. PubMed ID: 36566480
[TBL] [Abstract][Full Text] [Related]
18. Optimum non-invasive predictive indicators for metabolic dysfunction-associated fatty liver disease and its subgroups in the Chinese population: A retrospective case-control study.
Liu J; Duan S; Wang C; Wang Y; Peng H; Niu Z; Yao S
Front Endocrinol (Lausanne); 2022; 13():1035418. PubMed ID: 36531447
[TBL] [Abstract][Full Text] [Related]
19. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
